Cochrane Review: Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with

Zusammenfassung

Intravenöse vs. orale vs. keine Verabreichung von Eisen mit oder ohne Erythropoese‐stimulierenden Substanzen (erythropoiesis‐stimulating agents, ESAs) bei Krebspatienten mit Anämie: Ein systematischer Review und eine Netzwerk‐Metaanalyse - Adams, A - 2022 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012633.pub2/full/de?cookiesEnabled#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012633.pub2

Kerninformationen

in [About Cookies](http://olabout.wiley.com/WileyCDA/Section/id-813473.html). [I accept](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012633.pub2/full/de?cookiesEnabled#) [Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Revie...

mbination with or without ESAs to prevent or alleviate anaemia in cancer patients and to generate treatment rankings using network meta‐analyses (NMAs). ### Search methods We identified studies by searching bibliographic databases (CENTRAL, MEDLINE, Embase; until June 2021). We also searched vario...

tality, number of patients receiving red blood cell transfusions, number of red blood cell units, haematological response, overall mortality and adverse events. We conducted NMAs and generated treatment rankings. We assessed the certainty of the evidence using GRADE. ### Main results Ninety‐six tr...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen